Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Features predicting sentinel lymph node positivity in Merkel cell carcinoma.

Schwartz JL, Griffith KA, Lowe L, Wong SL, McLean SA, Fullen DR, Lao CD, Hayman JA, Bradford CR, Rees RS, Johnson TM, Bichakjian CK.

J Clin Oncol. 2011 Mar 10;29(8):1036-41. doi: 10.1200/JCO.2010.33.4136. Epub 2011 Feb 7.

2.

Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma.

Smith FO, Yue B, Marzban SS, Walls BL, Carr M, Jackson RS, Puleo CA, Padhya T, Cruse CW, Gonzalez RJ, Sarnaik AA, Schell MJ, DeConti RC, Messina JL, Sondak VK, Zager JS.

Cancer. 2015 Sep 15;121(18):3252-60. doi: 10.1002/cncr.29452. Epub 2015 Jun 2.

3.

A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.

Wat H, Senthilselvan A, Salopek TG.

J Am Acad Dermatol. 2016 Jan;74(1):94-101. doi: 10.1016/j.jaad.2015.09.014. Epub 2015 Nov 2.

PMID:
26542815
4.

The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.

Paek SC, Griffith KA, Johnson TM, Sondak VK, Wong SL, Chang AE, Cimmino VM, Lowe L, Bradford CR, Rees RS, Sabel MS.

Cancer. 2007 Jan 1;109(1):100-8.

5.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039
6.

Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?

Frankel TL, Griffith KA, Lowe L, Wong SL, Bichakjian CK, Chang AE, Cimmino VM, Bradford CR, Rees RS, Johnson TM, Sabel MS.

Ann Surg Oncol. 2008 Sep;15(9):2403-11. doi: 10.1245/s10434-008-0024-x. Epub 2008 Jul 15.

PMID:
18626721
7.

Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.

Jouary T, Kubica E, Dalle S, Pages C, Duval-Modeste AB, Guillot B, Mansard S, Saiag P, Aubin F, Bedane C, Dalac S, Dompmartin A, Granel-Brocard F, Lok C, Stoebner PE, Lacour JP, Leccia MT, Diallo A, Ezzedine K, Mateus C.

Acta Derm Venereol. 2015 Sep;95(7):835-40. doi: 10.2340/00015555-2099.

8.

Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients.

Ko JS, Prieto VG, Elson PJ, Vilain RE, Pulitzer MP, Scolyer RA, Reynolds JP, Piliang MP, Ernstoff MS, Gastman BR, Billings SD.

Mod Pathol. 2016 Feb;29(2):122-30. doi: 10.1038/modpathol.2015.109. Epub 2015 Nov 6.

9.

[Prognostic value of sentinel lymph node in Merkel cell carcinoma of the head and neck].

Penicaud M, Cammilleri S, Giorgi R, Taïeb D, Grob JJ, Giovanni A, Dessi P, Fakhry N.

Rev Laryngol Otol Rhinol (Bord). 2013;134(2):75-9. French.

PMID:
24683816
10.

Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature.

Maza S, Trefzer U, Hofmann M, Schneider S, Voit C, Krössin T, Zander A, Audring H, Sterry W, Munz DL.

Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):433-40. Epub 2006 Jan 24. Review.

PMID:
16432719
11.

Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases.

Shibayama Y, Imafuku S, Takahashi A, Nakayama J.

Int J Clin Oncol. 2015 Feb;20(1):188-93. doi: 10.1007/s10147-014-0685-3. Epub 2014 Apr 1.

PMID:
24687530
12.

Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.

Ann Surg. 2012 Jan;255(1):128-33. doi: 10.1097/SLA.0b013e3182306c72.

PMID:
21975320
13.

Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis.

Stokes JB, Graw KS, Dengel LT, Swenson BR, Bauer TW, Slingluff CL Jr, Ledesma EJ.

J Clin Oncol. 2009 Aug 10;27(23):3772-7. doi: 10.1200/JCO.2008.20.8272. Epub 2009 Jul 6.

14.

Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution.

Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Kraus DH, Brady MS, Coit DG.

Ann Surg Oncol. 2011 Sep;18(9):2529-37. doi: 10.1245/s10434-011-1662-y. Epub 2011 Mar 24.

15.

Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma.

Iyer JG, Storer BE, Paulson KG, Lemos B, Phillips JL, Bichakjian CK, Zeitouni N, Gershenwald JE, Sondak V, Otley CC, Yu SS, Johnson TM, Liegeois NJ, Byrd D, Sober A, Nghiem P.

J Am Acad Dermatol. 2014 Apr;70(4):637-43. doi: 10.1016/j.jaad.2013.11.031. Epub 2014 Feb 9.

16.

Significance of dual-basin drainage in patients with truncal melanoma undergoing sentinel lymph node biopsy.

Jacobs IA, Chang CK, Salti GI.

J Am Acad Dermatol. 2003 Oct;49(4):615-9.

PMID:
14512905
17.

Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma.

Düker I, Starz H, Bachter D, Balda BR.

Dermatology. 2001;202(3):225-9.

PMID:
11385228
18.

Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.

Feldmann R, Fink AM, Jurecka W, Rappersberger K, Steiner A.

Eur J Surg Oncol. 2014 Jan;40(1):73-6. doi: 10.1016/j.ejso.2013.08.022. Epub 2013 Sep 12.

PMID:
24075029
19.

Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

Sondak VK, Taylor JM, Sabel MS, Wang Y, Lowe L, Grover AC, Chang AE, Yahanda AM, Moon J, Johnson TM.

Ann Surg Oncol. 2004 Mar;11(3):247-58.

20.

Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Melanoma Res. 2003 Feb;13(1):35-43.

PMID:
12569283

Supplemental Content

Support Center